MLA Diagnostics
A multi-parameter non-invasive melanoma risk assessment tool
The Netherlands
10 employees
Venture round
Health Care, Medical Devices
General Information
The Netherlands
BounceWatch is an independent company data service, not affiliated with MLA Diagnostics. To contact MLA Diagnostics, visit mladx.com.
Is this your company?
Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.
Get Verified
How does MLA Diagnostics compare?
A PDF of MLA Diagnostics and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.
This takes a few seconds: we look beyond our own index too.
Meeting MLA Diagnostics soon?
A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample
Discover More
The Netherlands Market
Health Care
About MLA Diagnostics
Business keywords: Melanoma, Skin cancer, Prognostic test, IVD method, Pathologist, Metastatic risk, Early diagnosis, Cancer treatment, Innovation, Medical technology
Funding Rounds & Investors (2)
View All| Funding Stage | Amount | Investors | Lead Investors | Date |
|---|---|---|---|---|
| Venture Round | Undisclosed | 3 |
|
29 Nov 2023 |
| Pre Seed Round | Undisclosed | 1 |
NLC
|
05 Apr 2019 |
MLA Diagnostics Alternatives & Competitors
View All Alternatives
Driving Value to Dermatology Partners
Pioneering non-invasive skin cancer detection with advanced infrared laser and AI technology
Early lung cancer diagnosis with AI
FAQ About MLA Diagnostics
Source: BounceWatch company record for MLA Diagnostics, https://bouncewatch.com/company/mla-diagnostics, updated 25 September 2026. When citing, please name BounceWatch and link this page.
